61 - Long-Acting Antiretroviral Therapy for Treatment of HIV

Thursday, October 20, 2022

10:30 AM – 10:55 AM US ET

Location: Ballroom ABC (3rd Floor)

Watch the live stream on the conference website.

All relevant financial disclosures have been mitigated.

Speaker(s)

Charles W. Flexner, MD (he/him/his)

Professor
Johns Hopkins School of Medicine
Baltimore, MD, United States

Disclosure: Disclosure(s): Gilead Sciences: Advisor/Consultant (Ongoing); Janssen Pharmaceutical Company of J&J: Advisor/Consultant (Terminated); Merck and Company, Inc.: Advisor/Consultant (Ongoing); Navigen: Board Member (Ongoing); Viiv Healthcare: Advisor/Consultant (Ongoing)

Disclosure(s):

Charles W. Flexner, MD: Gilead Sciences: Advisor/Consultant (Ongoing); Janssen Pharmaceutical Company of J&J: Advisor/Consultant (Terminated); Merck and Company, Inc.: Advisor/Consultant (Ongoing); Navigen: Board Member (Ongoing); Viiv Healthcare: Advisor/Consultant (Ongoing)